Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actinides, lanthanides, and heavy metal ions represent a diverse group of exogenous elements that pose significant toxicological risks or serve specialized diagnostic roles. This group includes transuranic elements like Plutonium, Curium, and Californium, which are primarily radiological hazards, as well as heavy metals like Lead, which is a potent neurotoxin (Source: CDC, StatPearls). These ions are not traditional therapeutic targets such as receptors or enzymes; instead, they are the subjects of chelation therapy designed to facilitate their clearance from the body. In the case of lanthanides like Gadolinium, they are utilized as contrast agents in magnetic resonance imaging but require careful management to avoid systemic toxicity such as Nephrogenic Systemic Fibrosis (Source: FDA). The primary mechanism of pharmacological interaction involves the formation of stable coordination complexes with chelating agents like DTPA or EDTA, which enhances renal excretion. Managing these ions is crucial in clinical toxicology, radiology, and public health contexts to prevent organ damage and long-term health complications from environmental or industrial exposure.
Chelation therapy: The drugs act as ligands that form stable, water-soluble coordination complexes with the metal ions, preventing their binding to cellular components and facilitating renal or biliary excretion (Source: FDA, StatPearls).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actinide, lanthanide, and heavy metal ions.